WDNA vs. IDNA
Compare and contrast key facts about WisdomTree BioRevolution Fund (WDNA) and iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA).
WDNA and IDNA are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. WDNA is a passively managed fund by WisdomTree that tracks the performance of the WisdomTree BioRevolution Index. It was launched on Jun 3, 2021. IDNA is a passively managed fund by iShares that tracks the performance of the NYSE FactSet Global Genomics and Immuno Biopharma Index. It was launched on Jun 11, 2019. Both WDNA and IDNA are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: WDNA or IDNA.
Correlation
The correlation between WDNA and IDNA is 0.92, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Performance
WDNA vs. IDNA - Performance Comparison
Key characteristics
WDNA:
-0.48
IDNA:
0.20
WDNA:
-0.53
IDNA:
0.43
WDNA:
0.94
IDNA:
1.05
WDNA:
-0.22
IDNA:
0.07
WDNA:
-1.11
IDNA:
0.76
WDNA:
9.43%
IDNA:
5.66%
WDNA:
22.02%
IDNA:
21.03%
WDNA:
-51.90%
IDNA:
-68.26%
WDNA:
-47.12%
IDNA:
-57.94%
Returns By Period
In the year-to-date period, WDNA achieves a -13.52% return, which is significantly lower than IDNA's -0.68% return.
WDNA
-13.52%
-3.72%
-8.38%
-13.63%
N/A
N/A
IDNA
-0.68%
-1.61%
-4.22%
2.48%
-4.97%
N/A
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
WDNA vs. IDNA - Expense Ratio Comparison
WDNA has a 0.45% expense ratio, which is lower than IDNA's 0.47% expense ratio.
Risk-Adjusted Performance
WDNA vs. IDNA - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for WisdomTree BioRevolution Fund (WDNA) and iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
WDNA vs. IDNA - Dividend Comparison
WDNA has not paid dividends to shareholders, while IDNA's dividend yield for the trailing twelve months is around 0.98%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
WDNA WisdomTree BioRevolution Fund | 0.00% | 0.80% | 0.37% | 0.11% | 0.00% | 0.00% |
IDNA iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund | 0.98% | 1.04% | 0.54% | 0.70% | 0.26% | 0.80% |
Drawdowns
WDNA vs. IDNA - Drawdown Comparison
The maximum WDNA drawdown since its inception was -51.90%, smaller than the maximum IDNA drawdown of -68.26%. Use the drawdown chart below to compare losses from any high point for WDNA and IDNA. For additional features, visit the drawdowns tool.
Volatility
WDNA vs. IDNA - Volatility Comparison
WisdomTree BioRevolution Fund (WDNA) has a higher volatility of 7.42% compared to iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) at 6.42%. This indicates that WDNA's price experiences larger fluctuations and is considered to be riskier than IDNA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.